U.S. government partnering with Texas to build three mass vaccination
sites
Send a link to a friend
[February 11, 2021]
By Rebecca Spalding
(Reuters) - The federal government is
partnering with the state of Texas to build three mass vaccination
sites, following last week’s announcement that it would build such sites
in California, federal health officials said during a Wednesday media
briefing.
Each site will be able to administer 10,000 shots per day, according to
Jeffrey Zients, the White House’s COVID-19 response coordinator, and
should begin giving the shots by Feb. 22.
The sites will be in the Dallas and Houston areas and will be operated
by the Federal Emergency Management Agency (FEMA), according to a state
news release. One site will be AT&T Stadium in Arlington, Texas, home to
the Dallas Cowboys.
The federal government also plans to open vaccination hubs in the New
York City boroughs of Brooklyn and Queens on Feb. 24, each of which will
be able to administer about 3,000 shots a day, Zients said in an
announcement with New York Governor Andrew Cuomo.
[to top of second column]
|
Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen
in front of displayed USA flag in this illustration taken, February
9, 2021. REUTERS/Dado Ruvic/Illustration
Both the New York sites will receive special allocations of vaccines
from the federal government, and are intended to benefit Black and
Latino New Yorkers who have been disproportionately hit by the
pandemic, Cuomo said.
Last week, the state of California said it was partnering with FEMA
to open mass vaccination sites in Los Angeles and Oakland as a part
of a pilot program started by President Joe Biden's administration.
Both states said the program's goal was to make sure people in
underserved communities have access to vaccines.
(Reporting by Rebecca Spalding; Editing by Franklin Paul, Jonathan
Oatis and Bernadette Baum)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |